213 related articles for article (PubMed ID: 31958047)
1. Performance of the ResistancePlus MG diagnostic test for
Murray GL; Danielewski J; Bradshaw CS; Williamson DA; Birnie J; Su JP; De Petra V; Tan LY; Wee R; Machalek DA; Read TRH; Garland SM
J Med Microbiol; 2020 Feb; 69(2):244-248. PubMed ID: 31958047
[No Abstract] [Full Text] [Related]
2. Evaluation of ResistancePlus MG FleXible, a 'near-patient' test for the detection of
Murray GL; Doyle M; Bodiyabadu K; Vodstrcil LA; Garland SM; Danielewski J; Machalek DA; McGuinness C; Plummer EL; De Petra V; Williamson DA; Bradshaw CS
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33226320
[No Abstract] [Full Text] [Related]
3. Clinical Evaluation of Three Commercial PCR Assays for the Detection of Macrolide Resistance in Mycoplasma genitalium.
Le Roy C; Bébéar C; Pereyre S
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31801835
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide Resistance.
Tabrizi SN; Su J; Bradshaw CS; Fairley CK; Walker S; Tan LY; Mokany E; Garland SM
J Clin Microbiol; 2017 Jun; 55(6):1915-1919. PubMed ID: 28381611
[No Abstract] [Full Text] [Related]
5. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
[TBL] [Abstract][Full Text] [Related]
6. French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays.
Le Roy C; Pereyre S; Hénin N; Bébéar C
J Clin Microbiol; 2017 Nov; 55(11):3194-3200. PubMed ID: 28794183
[TBL] [Abstract][Full Text] [Related]
7. High levels of macrolide-resistant Mycoplasma genitalium in Queensland, Australia.
Trembizki E; Buckley C; Bletchly C; Nimmo GR; Whiley DM
J Med Microbiol; 2017 Oct; 66(10):1451-1453. PubMed ID: 28893363
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the
Pitt R; Cole MJ; Fifer H; Woodford N
Sex Transm Infect; 2018 Dec; 94(8):565-567. PubMed ID: 29101246
[TBL] [Abstract][Full Text] [Related]
9. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016.
Unemo M; Salado-Rasmussen K; Hansen M; Olsen AO; Falk M; Golparian D; Aasterød M; Ringlander J; Nilsson CS; Sundqvist M; Schønning K; Moi H; Westh H; Jensen JS
Clin Microbiol Infect; 2018 May; 24(5):533-539. PubMed ID: 28923377
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of the ResistancePlus MG FleXible test on the GeneXpert Infinity-48s instrument: a near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance.
Fernández-Huerta M; Salmerón P; Silgado A; Espasa M; Pumarola T; Tulsiani-Drud S; Barberá MJ; Hoyos-Mallecot Y; Serra-Pladevall J
Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115062. PubMed ID: 32451118
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Assays for the Diagnosis of Mycoplasma genitalium and Macrolide Resistance Mutations in Self-Collected Vaginal Swabs and Urine.
Chernesky M; Jang D; Martin I; Speicher DJ; Clavio A; Lidder R; Ratnam S; Smieja M; Arias M; Shah A
Sex Transm Dis; 2020 Oct; 47(10):705-711. PubMed ID: 32932404
[TBL] [Abstract][Full Text] [Related]
12. Performance of Three Commercial Molecular Diagnostic Assays for the Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance.
Le Roy C; Bébéar C; Pereyre S
J Clin Microbiol; 2021 May; 59(6):. PubMed ID: 33731412
[TBL] [Abstract][Full Text] [Related]
13.
Couldwell DL; Jalocon D; Power M; Jeoffreys NJ; Chen SC; Lewis DA
Sex Transm Infect; 2018 Sep; 94(6):406-410. PubMed ID: 29567802
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of commercial PCR assays for antimicrobal resistance in Mycoplasma genitalium and estimation of resistance-mediated mutation prevalence in Moscow and Moscow region.
Shedko ED; Khayrullina GA; Goloveshkina EN; Akimkin VG
Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1413-1418. PubMed ID: 33515097
[TBL] [Abstract][Full Text] [Related]
15. Levels of
Sweeney EL; Trembizki E; Bletchly C; Bradshaw CS; Menon A; Francis F; Langton-Lockton J; Nimmo GR; Whiley DM
J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30602443
[No Abstract] [Full Text] [Related]
16. Prevalence of Mycoplasma genitalium and Azithromycin-resistant Infections Among Remnant Clinical Specimens, Los Angeles.
Allan-Blitz LT; Mokany E; Campeau S; Wee R; Shannon C; Klausner JD
Sex Transm Dis; 2018 Sep; 45(9):632-635. PubMed ID: 29509566
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 5 commercial assays for the detection of Mycoplasma genitalium and other Urogenital Mycoplasmas.
Naidu P; Shokoples S; Martin I; Zelyas N; Singh A
Med Microbiol Immunol; 2021 Feb; 210(1):73-80. PubMed ID: 33595707
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the ResistancePlus MG FleXible Assay for Detection of Wild-Type and 23S rRNA-Mutated Mycoplasma genitalium Strains.
Drud ST; Njuguna P; Ebeyan S; Erskine S; Holm M; Johansson SC; Tan LY; Jensen JS
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31915287
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation.
Read TRH; Fairley CK; Murray GL; Jensen JS; Danielewski J; Worthington K; Doyle M; Mokany E; Tan L; Chow EPF; Garland SM; Bradshaw CS
Clin Infect Dis; 2019 Feb; 68(4):554-560. PubMed ID: 29873691
[TBL] [Abstract][Full Text] [Related]
20. The impact of sample storage on molecular-based detection of Mycoplasma genitalium.
Murray GL; Su JP; Birnie J; Danielewski J; Machalek DA; Bradshaw CS; Read TRH; Costa AM; Garland SM
J Appl Microbiol; 2019 Oct; 127(4):1219-1223. PubMed ID: 31220405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
